Cellular analysis market worth $28.6 billion by 2027

CHICAGO, May 31, 2022 /PRNewswire/ — According to new market research report Cellular Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technical (Flow Cytometry, High Content Screening), Process (Single Cell Analysis), End User (Pharmaceutical & Biotech Companies) – Global Forecast to 2027″, published by MarketsandMarkets™, the global market is expected to reach $28.6 billion by 2027 from $17.7 billion in 2022 at a CAGR of 10.1% over the forecast period.

Browse the in-depth table of contents at “Cell Analysis Market”
236 – Tables
38 – Numbers
236 – Pages

Download the PDF brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946

Rising number of discovery research studies is one of the major driving factors for the cell analysis market. The role of cell analysis in drug discovery has expanded significantly over the years, with the introduction of new technologies to the market that generate accurate results while minimizing the time required. This is also complemented by technological advances in the field of molecular biology, cell biology and genomics.

Software segment is estimated to grow with the highest CAGR during the forecast period of Cellular Analysis Market

Based on product and service, the global market is segmented into reagents and consumables, instruments, accessories, software and services. Cellular analysis software is an attractive market space attributed to advancements in cellular analysis, particularly in the areas of flow cytometry and single cell analysis. This has led to an increase in the number of emerging companies entering this market space. As a result, the software segment is expected to register the highest CAGR during the forecast period.

The flow cytometry technique segment accounted for the largest share of the cell analysis market in 2021

On the basis of technique, the global market is segmented into flow cytometry, PCR, cellular microarrays, microscopy, spectrophotometry, high content screening and other techniques. Flow cytometry segment accounted for the largest market share in 2021. Flow cytometry technique has gained popularity in different analytical processes including single cell analysis. This technique is capable of performing simultaneous measurement and analysis of distinct characteristics of single-celled particles as they flow in a fluid stream of a light beam.

Request sample pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=157543946

Single Cell Analysis Segment is Estimated to Grow with the Highest CAGR During the Forecast Period of Cell Analysis Market

Based on the process, the global market is segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting and quality control, cell interaction, cell structure study, identification and target validation and single cell analysis. Cellular analysis applications are expected to expand into the areas of therapeutics, research, and diagnostics attributed to the advent of single-cell analysis. This has made this segment with the fastest growth rate over the forecast period. Moreover, single-cell analysis is a powerful tool to assess single cells at multiple parameters, in a heterogeneous cell population.

Hospitals and Clinical Trial Labs Segment is Estimated to Grow with the Highest CAGR During the Forecast Period of the Cellular Analysis Market

On the basis of end users, the market is segmented into pharmaceutical and biotechnology companies, hospitals and clinical trial laboratories, academic and research institutes, and other end users. Demand for cell analysis products is expected to increase in in-house diagnostic and research centers, in-house pathology centers and reference laboratories; Collectively contributing to the fastest growth rate of hospitals and clinical trial laboratories over the forecast period. The development of highly specialized and complex cellular assays should complement this growth.

Talk to the analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=157543946

Asia Pacific recorded the fastest growth rate over the forecast period in the cell analysis market

The global market is segmented into North America, Europe, Asia Pacific, Latin Americaand the Middle East and Africa. The Asia Pacific the market is estimated to grow at the highest CAGR during the forecast period. Rapid rise in pharmaceutical and biopharmaceutical industries coupled with affordable cell analysis services are the major factors contributing to the regional growth.

Cellular analysis market is fragmented by nature with prominent players operating in this market such as Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (USA), Merck KGaA (USA), Agilent Technologies (USA), Olympus Corporation (Japan), Miltenyi Biotec (USA), Bio-Rad Laboratories (USA), BioStatus Limited (UK), Fluidigm Corporation (USA), NanoCellect Biomedical (USA), Cell Biolabs (USA ), Creative Bioarray (USA), Meiji Techno (USA), Promega Corporation (USA), PerkinElmer (USA), Tecan Trading AG (Swiss), CELLINK (USA), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US) and Illumina (US).

Browse adjacent markets: Biotech Market Research Reports and Advice

Browse related reports:

Microscopy market by product (microscopes, software, accessories), type (optical microscope (stereo, digital), electron microscope (SEM, TEM), AFM, STM), application (semiconductor, life sciences), end user (industrial, research) (2022 – 2026)

Single Cell Analysis Market by cell type (human, animal, microbial), product (consumables, instrument), technique (flow cytometry, NGS, PCR, microscopy, MS), application (research, medical), end user (pharmacy, biotech, hospitals) – Global Forecast to 2026

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats that will impact 70%-80% of global business revenue. Currently serving 7,500 customers worldwide, including 80% of global Fortune 1000 companies as customers. Nearly 75,000 senior executives from eight industries around the world approach MarketsandMarkets™ for their revenue decision issues.

Our 850 full-time analysts and MarketsandMarkets™ SMEs track global high-growth markets by following the “Growth Engagement Model – GEM”. The GEM aims for proactive collaboration with customers to identify new opportunities, identify most important customers, write “Attack, Avoid and Defend” strategies, identify additional sources of revenue for the company and its competitors. MarketsandMarkets™ now offers 1,500 MicroQuadrants (positioning top performers among Leaders, Emerging Companies, Innovators, Strategic Players) each year in high-growth emerging segments. MarketsandMarkets™ is determined to benefit over 10,000 companies this year for their revenue planning and help them bring their innovations/disruptions to market by providing research ahead of the curve.

MarketsandMarkets’ flagship competitive intelligence and market research platform, “Knowledge Store”, connects over 200,000 markets and entire value chains for a deeper understanding of unmet information, as well as market sizing and niche market forecasts.

Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Office 430
Northbrook, IL 60062
UNITED STATES: +1-888-600-6441
E-mail: [email protected]
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/cell-analysis-market.asp
Visit our website: https://www.marketsandmarkets.com
Source of content: https://www.marketsandmarkets.com/PressReleases/cell-analysis.asp

SOURCE Markets and Markets

Source link